Clinical Trials

Showing trials with last updates posted in 2025.

NCT05216432 | RECRUITING | PHASE1
930 participants

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-22
Start Date:
2021-12-08
Completion:
2027-04-30
Conditions
  • PIK3CA Mutation
  • Solid Tumor, Adult
  • HER2-negative Breast Cancer
  • Breast Cancer
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • Unresectable Solid Tumor
Interventions
  • DRUG
No Results Yet
NCT05022264 | RECRUITING
860 participants

Remote Investigation and Assessment of Vital Signs

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-22
Start Date:
2022-03-01
Completion:
2027-06-30
Conditions
  • Blood Pressure
  • Pulse Rate
  • Respiratory Rate
  • Oxygen Saturation
  • Body Temperature
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page